Further , the report states that one challenge in market is high regulations of plasma products . Manufacturers of critical care therapeutics need to follow rigorous and distinct sets of regulatory guidelines like the adherence to current good manufacturing practices ( cGMP ) during the donation and processing of the plasma products . These guidelines are applied both for the collection of plasma from donors and during the fractionation of plasma-derived products along with the manufacture and production of the final product . Various regulatory bodies like the WHO ; European Commission Directorate-General for Health and Consumers ( DG SANCO ), EMA , EDQM , and NCAs in the EU ; HHS , US FDA , and the CDC , in the US ; and Anvisa and COFEPRIS in ROW regulate these processes . Also , the approval process for plasma products is very long . For instance , in China , the plasma products have to go through 10 different stages , which takes a minimum of 22-28 months to receive approval for commercialization in the market by the CFDA . Since the plasma collection and manufacturing units are required to follow these guidelines , which requires high cost and efficiency , many of the new players are unable to enter the market , thus hindering the market growth .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry . The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors .
About Critical Care Therapeutics
Critical care or intensive care is the close monitoring and treatment given to individuals with acute , life-threatening illness or injuries such as shock , burns , accidents , complicated surgeries , sepsis , and severe breathing problems . It usually takes place in an ICU or trauma center . Plasma is the fluid portion of the blood , in which all the blood cells are suspended . It makes up about 55 % of the total volume of the blood . The other components such as red blood cell ( RBC ), white blood cell ( WBC ), and platelets together comprise the remaining 45 % of the blood . Plasma is mainly made up of water , which accounts for about 91 % of the total volume .
Complete Report Details @ https :// marketreportscenter . com / reports / 500950 / global-critical-caretherapeutics-market-2017-2021
Covered in this report
The report covers the present scenario and the growth prospects of the global critical care therapeutics market for 2017-2021 . To calculate the market size , the report considers the revenue generated from sales of critical care therapeutics was considered .
The market is divided into the following segments based on geography : Americas APAC EMEA
Global Critical Care Therapeutics Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts . The report covers the market landscape and its growth prospects over the coming years . The report also includes a discussion of the key vendors operating in this market .
Key vendors